Tech & industry

Rehabilitation robotics leader Fourier Intelligence is further increasing its prominence on a global scale through its expansion into Europe and Australia, while also relocating its headquarters into the hugely sought-after ‘Silicon Valley of the East’. 

Thousands of organisations and individuals across the UK have benefitted from an initiative to support people with communication difficulties since its launch a year ago. 

Helius Medical Technologies is playing an increasingly central role in the growth of the neurostimulation market globally. Its PoNS device is changing the lives of MS patients in North America and helping to demonstrate the impact of non-invasive technology in neurological disorders. NR Times speaks to Helius’ CEO Dane Andreeff about its pioneering work

Concussion could be detected and evaluated by a video taken on a smart device, through the use of an app which monitors the eye’s reaction to light. 

A new European initiative will see the development of a collaborative platform for data and sample sharing for neurodegenerative diseases. 

A new technology-led neurorehabilitation centre has opened to offer high-intensity programmes of physiotherapy, advancing the recovery of people with neurological injury or illness from across the UK. 

While breakthroughs in cancer treatment over the past 40 years have been truly life-changing, with recovery prospects and life expectancy in many common cancers revolutionised, that sadly is not true with regard to glioblastoma (GBM). 

Due to the improvement of medicine and the consequent increase in overall life expectancy, the prevalence of neurological disorders and need for neurorehab among the population is becoming higher and higher.

The iReadMore app - created to support people with aphasia or acquired reading impairments due to stroke, brain injury or dementia - is continuing to grow, driven by the positive experiences of users worldwide whose reading abilities have recovered significantly as a result of its use. 

An AI-powered test for the early detection of dementia has secured FDA Clearance, enabling the pioneering technology to be adopted across the United States and supporting its expansion plans around the world.